evidence table
Peppermint Oil Dyspepsia Randomized Trial Evidence Table
Structured evidence table for Peppermint Oil Dyspepsia Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Peppermint Oil Dyspepsia Randomized Trial | The S1 guideline summarizes the current state of knowledge and allows a targeted approach based on the currently available medical evidence. | 2 | Storr M (2026) | S1 Guideline of the German Society for Neurogastroenterology and Motility (DGNM) on Functional Dyspepsia (FD), a Disorder of Gut-Brain Interaction (DGBI) [English Language Edition]. |
| Peppermint Oil Dyspepsia Randomized Trial | Functional dyspepsia (FD) is common and classified as a disorder of gut-brain interaction (DGBI). | 2 | Storr M (2026) | S1 Guideline of the German Society for Neurogastroenterology and Motility (DGNM) on Functional Dyspepsia (FD), a Disorder of Gut-Brain Interaction (DGBI) [English Language Edition]. |
| Peppermint Oil Dyspepsia Randomized Trial | Diagnosis is based on symptoms, which are classified according to the Rome IV criteria, in combination with diagnostic procedures that may include laboratory testing, Helicobacter pylori testing, upper gastrointestinal endoscopy, abdominal ultrasound, and other examinations, depending on the severity, duration, and presence of alarm symptoms. | 2 | Storr M (2026) | S1 Guideline of the German Society for Neurogastroenterology and Motility (DGNM) on Functional Dyspepsia (FD), a Disorder of Gut-Brain Interaction (DGBI) [English Language Edition]. |
| Peppermint Oil Dyspepsia Randomized Trial | Results During treatment, all assessed abdominal symptoms showed significant (p Conclusion The study demonstrates patient-relevant improvement in gastrointestinal symptoms during treatment with Menthacarin while underlining its favorable tolerability profile. | 2 | Linas I (2025) | Treatment of disorders of gut-brain interaction with peppermint oil and caraway oil combination Menthacarin : A phase IV clinical trial. |
| Peppermint Oil Dyspepsia Randomized Trial | Introduction In disorders of gut-brain interaction including functional dyspepsia and irritable bowel syndrome, clinical focus has shifted from pathophysiological criteria to symptoms. | 2 | Linas I (2025) | Treatment of disorders of gut-brain interaction with peppermint oil and caraway oil combination Menthacarin : A phase IV clinical trial. |
| Peppermint Oil Dyspepsia Randomized Trial | Methods A single-arm, low-intervention clinical trial into the effectiveness and tolerability of Menthacarin, a peppermint oil/caraway oil combination, was performed. | 2 | Linas I (2025) | Treatment of disorders of gut-brain interaction with peppermint oil and caraway oil combination Menthacarin : A phase IV clinical trial. |
Source documents
- S1 Guideline of the German Society for Neurogastroenterology and Motility (DGNM) on Functional Dyspepsia (FD), a Disorder of Gut-Brain Interaction (DGBI) [English Language Edition].
- Treatment of disorders of gut-brain interaction with peppermint oil and caraway oil combination Menthacarin : A phase IV clinical trial.